# The unintended consequences of the 340B safety‐net drug discount program

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-unintended-consequences-of-the-340b-safety-net-drug-discount-program/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Samuel Thomas,Kevin A. Schulman |
| Citations | 18 |
| DOI | 10.1111/1475-6773.13281 |
| Fields | Economics, Econometrics and Finance,Health Professions |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7080379 |
| OpenAlex ID | https://openalex.org/W3008525320 |
| PMID | 32114714 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Samuel Thomas](https://scholariq.org/researchers/samuel-thomas/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Healthcare cost, quality, practices](https://scholariq.org/topics/healthcare-cost-quality-practices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.